Q. What are Fixed Dose Combination (FDC) medicines? Discuss their benefits and challenges in improving healthcare. (15 marks 250 Words).
Question
Q. What are Fixed Dose Combination (FDC) medicines? Discuss their benefits and challenges in improving healthcare. (15 marks 250 Words)
Model Answer
What are Fixed Dose Combination (FDC) medicines? Discuss their benefits and challenges in improving healthcare. (15 marks 250 Words)
Paper
GS III
Subject
Science & Technology
Syllabus as Per Notification
Science and Technology- Developments and their Applications and Effects in Everyday Life.
Topic
Fixed Dose Combination (FDC) medicines – Pros and Cons
Approach:
Introduction
Introduce by defining Fixed Dose Combination (FDC) medicines
Body
Discuss the Benefits of FDC Medicines
Improved patient compliance, Enhanced therapeutic efficacy, Reduced risk of resistance, Lower treatment costs and simplified supply chain, Rational FDCs simplify multi-disease management and Standardization of treatment regimens.
Challenges of FDCs in Improving Healthcare
Irrational Combinations and Lack of Evidence, Increasing Antimicrobial Resistance (AMR), Higher Adverse Drug Reactions, Diagnostic Masking and Worsening Conditions and Regulatory and Governance Failures.
Way Forward
Strengthening Regulatory Oversight, Aligning with Global Standards, Promoting responsible use of Antibiotics and Enhancing Pharmacovigilance.
Conclusion
Conclude by emphasising scientific evidence and effective regulation for FDCs to realise Universal Health Coverage (UHC) under SDG 3.
Context
Union Ministry of Health and Family Welfare Prohibits Manufacture, Sale and Distribution of 16 Fixed Dose Combinations (FDCs) in Public Interest.
Introduction
Fixed Dose Combination (FDC) medicines are pharmaceutical formulations containing two or more active ingredients in a fixed proportion within a single dosage form (tablet, capsule, syrup, cream or injection). They are intended to improve therapeutic effectiveness, patient convenience and treatment adherence. However, irrational combinations can compromise patient safety and contribute to antimicrobial resistance (AMR).
Some of popular FDCs are Augmentin 625 (Amoxicillin + Clavulanic Acid), Norflox-TZ (Norfloxacin + Tinidazole).
Body
Benefits of FDC Medicines
Improved patient compliance:
Reducing pill burden simplifies adherence, which is critical for managing chronic diseases like tuberculosis (TB), HIV/AIDS, hypertension, and diabetes.
Example: WHO recommends multi-drug FDCs in TB therapy to ensure adherence.
Enhanced therapeutic efficacy
Combining drugs with complementary mechanisms can produce a synergistic effect, as seen in the rational combination of Amoxicillin + Clavulanic acid (Augmentin), where clavulanic acid blocks resistance enzymes.
Reduced risk of resistance
In Diseases like TB and HIV, FDCs prevent microbial resistance by ensuring simultaneous multi-drug action.
Lower treatment costs and simplified supply chain
Fewer prescriptions and streamlined procurement, storage, and distribution make FDCs more affordable and logistically efficient for public Health programmes.
India's National Tuberculosis Elimination Programme (NTEP) uses FDCs to simplify inventory management and ensure complete regimen delivery.
Rational FDCs simplify multi-disease management
By combining complementary drugs into a single pill, FDCs will enable simultaneous treatment of co-existing conditions.
Metformin + Glimepiride for diabetes and Amlodipine + Atenolol for hypertension.
Standardization of treatment regimens:
FDCs reduce variability in prescribing practices, ensuring consistent and evidence-based care delivery across different healthcare settings.
Challenges of FDCs in Improving Healthcare
Irrational Combinations and Lack of Evidence
Many FDCs lack scientific justification.
Amoxicillin + Serratiopeptidase is irrational because serratiopeptidase is acid-labile (degrades in the stomach) and no evidence shows it improves bacterial clearance.
Increasing Antimicrobial Resistance (AMR)
Irrational antibiotic combinations create selective pressure, allowing resistant organisms to survive and spread, thereby accelerating AMR.
Example: Norflox-TZ (Norfloxacin + Tinidazole) is an irrational FDC, as bacterial and amoebic diarrhoea rarely coexist, leading to unnecessary antibiotic use.
Higher Adverse Drug Reactions
Combining multiple active ingredients increases the risk of toxicity, allergies and drug interactions by exposing patients to unnecessary medicines.
Nimesulide + Paracetamol increases the risk of liver toxicity without offering significant additional therapeutic benefit over paracetamol alone.
Diagnostic Masking and Worsening Conditions
Topical combinations pairing a steroid and an antifungal can provide temporary relief while suppressing local immunity, allowing underlying fungal infections to worsen and spread.
Misuse of Clobetasol-based combination creams can cause tinea incognito.
Regulatory and Governance Failures
In the pre-reform period in India, thousands of FDCs were approved by state licensing authorities without central review, exploiting a loophole in the Drugs & Cosmetics Act.
This allowed products like aloe vera-based creams to persist for years without evidence.
Way Forward
Strengthening Regulatory Oversight:
Ensure rigorous, scientific evaluation of all FDCs by Central Drugs Standard Control Organisation (CDSCO), building on the Drugs Technical Advisory Board (DTAB) Expert Committee's review of irrational FDCs pursuant to the Supreme Court's directions.
Aligning with Global Standards:
Follow practices in the US, EU, and WHO, which mandate clinical evidence and scientific review for FDC approval.
WHO explicitly cautions against irrational FDCs and only combinations on its Essential Medicines List are treated as evidence-based.
Promoting responsible use of Antibiotics
Encourage evidence-based prescribing and prescription audits, while strengthening public awareness through initiatives such as the Red Line Campaign, which promotes the use of antibiotics only on a doctor's prescription and discourages over-the-counter sale and misuse.
Enhancing Pharmacovigilance:
Continuously monitor the safety and efficacy of FDCs and withdraw irrational combinations, as recommended by expert committees such as the Kokate Committee.
Institutionalize the post-2016 review mechanism as a permanent, periodic exercise to prevent irrational FDCs from re-entering the market.
Conclusion
Fixed Dose Combination medicines can be a powerful tool for achieving safe, affordable and accessible healthcare when backed by robust scientific evidence and effective regulation. Strengthening CDSCO oversight, promoting rational prescribing and the responsible use of antibiotics, and aligning with WHO standards will ensure that only rational FDCs reach patients. This will support India's goal of Universal Health Coverage (UHC) under SDG 3 while combating the growing threat of antimicrobial resistance.